Oncolab, Inc.'s AMAS® Test is a commercially available blood test that may allow early detection of a wide range of human cancers. It detects a circulating, cancer-specific antibody, the Anti-malignin antibody, in human serum. Oncolab has been granted additional patent claims covering advances in its antibody and antigen detection techniques, as well as potential vaccine applications of the technology.
The California Lyme Disease Association warns that President Bush may not be cured of Lyme disease. Although he finished one course of treatment, symptoms can return months or years later.